BRCA1 Gene Mutation: Clinical Trials

2 trials for BRCA1 Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow BRCA1 Gene Mutation: new trials by email Literature Review of BRCA1 Gene Mutation trials Research Report on BRCA1 Gene Mutation

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects
Niraparib, Niraparib Tosylate Monohydrate, Radical Prostatectomy - ATM Gene Mutation, BRCA1 Gene Mutation
Phase 2TerminatedUniversity of California, Davis112020-02-252026-05-14
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
Carboplatin, Docetaxel, Laboratory Biomarker Analysis - ATM Gene Mutation, BRCA1 Gene Mutation
Phase 2TerminatedUniversity of Washington182018-08-242026-08-26

Narrower conditions

Prostatic Neoplasms (1)

Broader conditions

Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Prostatic Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)

Interventions

Carboplatin (1)  ·  Docetaxel (1)  ·  niraparib (1)  ·  rucaparib (1)

Sponsors

University of California, Davis (1)  ·  University of Washington (1)

Countries

United States (2)

Top investigators

Heather H. Cheng (1)  ·  Marc Dall'Era (1)

Results publications

PMID 36710203

NIH funding

P30CA093373 (1)